menu search

Viracta Therapeutics to Present at the Stifel 2023 Targeted Oncology Days

Viracta Therapeutics to Present at the Stifel 2023 Targeted Oncology Days
SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, its President and Chief Executive Officer, and Lisa Rojkjaer, M.D., its Chief Medical Officer, are scheduled to participate in a […] The post Viracta Therapeutics to Present at the Stifel 2023 Targeted Oncology Days appeared first on ForexTV... Read More
Posted: Apr 19 2023, 20:30
Author Name: forextv
Views: 102441

Search within

Pages Search Results: